Efficacy and safety of different doses of cytarabine in consolidation therapy for adult acute myeloid leukemia patients: a network meta-analysis
Author:
Publisher
Springer Science and Business Media LLC
Subject
Multidisciplinary
Link
http://www.nature.com/articles/s41598-017-10368-0.pdf
Reference33 articles.
1. Burnett, A., Wetzler, M. & Lowenberg, B. Therapeutic Advances in Acute Myeloid Leukemia. J Clin Oncol 29, 487–494, doi: 10.1200/JCO.2010.30.1820 (2011).
2. Dohner, H. et al. Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet. Blood 115, 453–474, doi: 10.1182/blood-2009-07-235358 (2010).
3. Dohner, H., Weisdorf, D. J. & Bloomfield, C. D. Acute Myeloid Leukemia. N Engl J Med 373, 1136–1152, doi: 10.1056/NEJMra1406184 (2015).
4. Rowe, J. M. Consolidation therapy: What should be the standard of care? Best Pract Res Clin Haematol 21, 53–60, doi: 10.1016/j.beha.2007.11.004 (2008).
5. Schlenk, R. F. Post-remission therapy for acute myeloid leukemia. Haematologica 99, 1663–1670, doi: 10.3324/haematol.2014.114611 (2014).
Cited by 24 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Single dose of peg GCSF compared with daily GCSF in de novo acute myeloid leukemia patients on high dose cytarabine consolidation chemotherapy (HIDAC);2024-01-05
2. Impact of different chemotherapy regimens on intestinal mucosal injury assessed with bedside ultrasound: a study in 213 AML patients;Frontiers in Oncology;2023-11-01
3. Outpatient consolidation chemotherapy with intermediate dose cytarabine has similar survival and relapses rates in acute myeloid leukemia as compared to high dose cytarabine: A single center analysis;European Journal of Haematology;2023-08-28
4. Toxicity and outcome of adults with acute myeloid leukemia receiving consolidation with high-dose cytarabine;Hematology, Transfusion and Cell Therapy;2023-08
5. A clinical report on high‑dose cytarabine therapy for children with acute myeloid leukemia;Molecular and Clinical Oncology;2022-10-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3